RNA Modification in Inflammatory Bowel Diseases

Mika Nakayama, Yuki Ozato, Yoshiko Tsuji, Yasuko Arao, Chihiro Otsuka, Yumiko Hamano, Genzo Sumi, Ken Ofusa, Shizuka Uchida, Andrea Vecchione, Hideshi Ishii*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Downloads (Pure)


Inflammatory bowel disease (IBD) is a chronic inflammatory disorder characterized by damage to the intestinal mucosa, which is caused by a combination of factors. These include genetic and epigenetic alterations, environmental influence, microorganism interactions, and immune conditions. Some populations with IBD show a cancer-prone phenotype. Recent studies have provided insight into the involvement of RNA modifications in the specific pathogenesis of IBD through regulation of RNA biology in epithelial and immune cells. Studies of several RNA modification-targeting reagents have shown preferable outcomes in patients with colitis. Here, we note a new awareness of RNA modification in the targeting of IBD and related diseases, which will contribute to early diagnosis, disease monitoring, and possible control by innovative therapeutic approaches.
Original languageEnglish
Article number1695
Issue number7
Publication statusPublished - 13 Jul 2022


  • RNA modification
  • inflammatory bowel disease


Dive into the research topics of 'RNA Modification in Inflammatory Bowel Diseases'. Together they form a unique fingerprint.

Cite this